GlassScriptPhysician profile
James Zucherman
NPI 1194887760
$6,363.88
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,231 · 2020: $193 · 2021: $114 · 2022: $2,358 · 2023: $271 · 2024: $197.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $468.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $467.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Benvenue Medical INC | $2,766.21 | 2019 | |
| Medacta USA, INC. | $1,050.24 | 2022 | |
| Relievant Medsystems, INC. | $867.35 | 2019-2022 | |
| Stryker Corporation | $751.08 | 2019-2023 | N/A |
| Spineart USA INC | $553.69 | 2022-2024 | Perla Tl |
| Vertiflex, INC. | $146.92 | 2019 | |
| Amgen INC. | $55.60 | 2020-2022 | |
| Titan Spine, LLC | $43.96 | 2019 | |
| Si-Bone, INC. | $38.91 | 2020-2024 | |
| Medtronic USA, INC. | $26.22 | 2019 | |
| Davol INC. | $24.33 | 2021 | |
| Orthofix Medical, INC. | $20.83 | 2023 | Truelok, Galaxy Fixation Gemini, Galaxy Fixation System |
| Baudax Bio INC. | $18.54 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Zucherman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.